Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138587985> ?p ?o ?g. }
- W2138587985 endingPage "562" @default.
- W2138587985 startingPage "553" @default.
- W2138587985 abstract "The extremely high prevalence of HIV/AIDS in sub-Saharan Africa and limitations of current antiretroviral medicines demand new tools to optimize therapy such as pharmacogenomics for person-to-person variations. African populations exhibit greater genetic diversity than other world populations, thus making it difficult to extrapolate findings from one population to another. Nevirapine, an antiretroviral medicine, displays large plasma concentration variability which adversely impacts therapeutic virological response. This study, therefore, aimed to identify sources of variability in nevirapine pharmacokinetics and pharmacodynamics, focusing on genetic variation in CYP2B6 and CYP1A2. Using a cross-sectional study design, 118 HIV-infected adult Zimbabwean patients on nevirapine-containing highly active antiretroviral therapy (HAART) were characterized for three key functional single nucleotide polymorphisms (SNPs), CYP2B6 c.516G>T (rs3745274), CYP2B6 c.983T>C (rs28399499), and CYP1A2 g.-163C>A (rs762551). We investigated whether genotypes at these loci were associated with nevirapine plasma concentration, a therapeutic biomarker, and CD4 cell count, a biomarker of disease progression. CYP2B6 and CYP1A2 were chosen as the candidate genes based on reports in literature, as well as their prominence in the metabolism of efavirenz, a drug in the same class with nevirapine. Nevirapine plasma concentration was determined using LC-MS/MS. The mean nevirapine concentration for CYP2B6 c.516T/T genotype differed significantly from that of 516G/G (p < 0.001) and 516G/T (p < 0.01) genotypes, respectively. There were also significant differences in mean nevirapine concentration between CYP2B6 c.983T > C genotypes (p = 0.04). Importantly, the CYP1A2 g.-163C>A SNP was significantly associated with the pharmacodynamics endpoint, the CD4 cell count (p = 0.012). Variant allele frequencies for the three SNPs observed in this Zimbabwean group were similar to other African population groups but different to observations among Caucasian and Asian populations. We conclude that CYP2B6 c.516G>T and CYP2B6 c.983T>C could be important sources of nevirapine pharmacokinetic variability that could be considered for dosage optimization, while CYP1A2 g.-163C>A seems to be associated with HIV disease progression. These inter- and intra-population pharmacokinetic and pharmacodynamics differences suggest that a single prescribed dosage may not be appropriate for the treatment of disease. Further research into a personalized nevirapine regimen is required." @default.
- W2138587985 created "2016-06-24" @default.
- W2138587985 creator A5013508569 @default.
- W2138587985 creator A5028414326 @default.
- W2138587985 creator A5038440890 @default.
- W2138587985 creator A5040124117 @default.
- W2138587985 creator A5042743299 @default.
- W2138587985 creator A5047773727 @default.
- W2138587985 creator A5050659589 @default.
- W2138587985 creator A5053945845 @default.
- W2138587985 creator A5062544472 @default.
- W2138587985 creator A5067318127 @default.
- W2138587985 creator A5068472866 @default.
- W2138587985 creator A5079792774 @default.
- W2138587985 date "2015-09-01" @default.
- W2138587985 modified "2023-09-23" @default.
- W2138587985 title "Effects of<i>CYP2B6</i>and<i>CYP1A2</i>Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients" @default.
- W2138587985 cites W115249897 @default.
- W2138587985 cites W1199118532 @default.
- W2138587985 cites W1449209446 @default.
- W2138587985 cites W1511363443 @default.
- W2138587985 cites W1556631311 @default.
- W2138587985 cites W1812712408 @default.
- W2138587985 cites W1966889975 @default.
- W2138587985 cites W1973662650 @default.
- W2138587985 cites W1982589515 @default.
- W2138587985 cites W1992008940 @default.
- W2138587985 cites W1999148106 @default.
- W2138587985 cites W2002040298 @default.
- W2138587985 cites W2003321739 @default.
- W2138587985 cites W2009080279 @default.
- W2138587985 cites W2013379543 @default.
- W2138587985 cites W2014983717 @default.
- W2138587985 cites W2018158288 @default.
- W2138587985 cites W2031512225 @default.
- W2138587985 cites W2032735163 @default.
- W2138587985 cites W2048334324 @default.
- W2138587985 cites W2048776156 @default.
- W2138587985 cites W2049761843 @default.
- W2138587985 cites W2055152709 @default.
- W2138587985 cites W2058627164 @default.
- W2138587985 cites W2061808383 @default.
- W2138587985 cites W2073897466 @default.
- W2138587985 cites W2074068205 @default.
- W2138587985 cites W2083079333 @default.
- W2138587985 cites W2085199878 @default.
- W2138587985 cites W2089894476 @default.
- W2138587985 cites W2095442537 @default.
- W2138587985 cites W2097781012 @default.
- W2138587985 cites W2100921566 @default.
- W2138587985 cites W2104810332 @default.
- W2138587985 cites W2105010850 @default.
- W2138587985 cites W2106437551 @default.
- W2138587985 cites W2107227728 @default.
- W2138587985 cites W2108823596 @default.
- W2138587985 cites W2108835974 @default.
- W2138587985 cites W2109808952 @default.
- W2138587985 cites W2110868212 @default.
- W2138587985 cites W2113275980 @default.
- W2138587985 cites W2118504160 @default.
- W2138587985 cites W2121074897 @default.
- W2138587985 cites W2123211579 @default.
- W2138587985 cites W2123793482 @default.
- W2138587985 cites W2125675654 @default.
- W2138587985 cites W2130384515 @default.
- W2138587985 cites W2132801707 @default.
- W2138587985 cites W2134294082 @default.
- W2138587985 cites W2135892517 @default.
- W2138587985 cites W2140026462 @default.
- W2138587985 cites W2140561708 @default.
- W2138587985 cites W2144360398 @default.
- W2138587985 cites W2147458465 @default.
- W2138587985 cites W2152293167 @default.
- W2138587985 cites W2154703395 @default.
- W2138587985 cites W2159375095 @default.
- W2138587985 cites W2163636261 @default.
- W2138587985 cites W2167794954 @default.
- W2138587985 cites W2170947401 @default.
- W2138587985 cites W2327551616 @default.
- W2138587985 cites W2527229227 @default.
- W2138587985 cites W3042812874 @default.
- W2138587985 cites W4233079875 @default.
- W2138587985 cites W2117695093 @default.
- W2138587985 doi "https://doi.org/10.1089/omi.2015.0104" @default.
- W2138587985 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4575538" @default.
- W2138587985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26348712" @default.
- W2138587985 hasPublicationYear "2015" @default.
- W2138587985 type Work @default.
- W2138587985 sameAs 2138587985 @default.
- W2138587985 citedByCount "19" @default.
- W2138587985 countsByYear W21385879852016 @default.
- W2138587985 countsByYear W21385879852018 @default.
- W2138587985 countsByYear W21385879852019 @default.
- W2138587985 countsByYear W21385879852020 @default.
- W2138587985 countsByYear W21385879852021 @default.
- W2138587985 countsByYear W21385879852022 @default.
- W2138587985 countsByYear W21385879852023 @default.
- W2138587985 crossrefType "journal-article" @default.